Cargando…

Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer

Background: FNDC5 belongs to the family of proteins called fibronectin type III domain-containing which carry out a variety of functions. The expression of FNDC5 is associated with the occurrence and development of tumors. However, the role of FNDC5 in gastric cancer remains relatively unknown. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Luyun, Ye, Yan, Sun, Yuqin, Zhong, Wenting, Chi, Liangjie, Lin, Youyu, Liu, Hongxia, Li, ShengZhao, Chen, Hui, Li, Chengcheng, Lin, Yuxuan, Wang, Qingshui, Xue, Fangqin, Lin, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649517/ https://www.ncbi.nlm.nih.gov/pubmed/36386179 http://dx.doi.org/10.3389/fphar.2022.981201

Ejemplares similares

Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma
por: Zhong, Wenting, et al.
Publicado: (2022)

FNDC5/Irisin: Physiology and Pathophysiology
por: Waseem, Rashid, et al.
Publicado: (2022)

Expression of Irisin/FNDC5 in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2022)

Progress and Challenges in the Biology of FNDC5 and Irisin
por: Maak, Steffen, et al.
Publicado: (2021)

High DAPK1 Expression Promotes Tumor Metastasis of Gastric Cancer
por: Wang, Qingshui, et al.
Publicado: (2022)

Irisin/FNDC5: A participant in camel metabolism
por: Kirat, Doaa, et al.
Publicado: (2021)

FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine
por: Roca-Rivada, Arturo, et al.
Publicado: (2013)

The diagnostic value of FNDC5/Irisin in renal Cell Cancer
por: Altay, Diler Us, et al.
Publicado: (2018)

Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment
por: Peng, Jin, et al.
Publicado: (2022)

Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor?
por: Erickson, Harold P
Publicado: (2013)

Exercise-Linked Skeletal Irisin Ameliorates Diabetes-Associated Osteoporosis by Inhibiting the Oxidative Damage–Dependent miR-150-FNDC5/Pyroptosis Axis
por: Behera, Jyotirmaya, et al.
Publicado: (2022)

Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
por: Li, Feng, et al.
Publicado: (2022)

New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
por: Rabiee, Farzaneh, et al.
Publicado: (2020)

FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
por: Pignataro, Patrizia, et al.
Publicado: (2021)

Evaluation of Serum Concentration of the Myokine Irisin (FNDC5) in Patients with Age-Related
por: Turgut, Burak, et al.
Publicado: (2021)

Irisin Precursor FNDC5 and Glycemic Control in Patients With Type 2 Diabetes
por: Lima Mágero, Felipe Rodrigues, et al.
Publicado: (2021)

Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression
por: Lima-Filho, Ricardo, et al.
Publicado: (2023)

The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2023)

Locus Characterization and Gene Expression of Bovine FNDC5: Is the Myokine Irisin Relevant in Cattle?
por: Komolka, Katrin, et al.
Publicado: (2014)

Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis
por: Pérez-Sotelo, D., et al.
Publicado: (2017)

Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC
por: Nowińska, Katarzyna, et al.
Publicado: (2022)

Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis
por: Sanesi, Lorenzo, et al.
Publicado: (2023)

Regulatory Non-coding RNAs for Death Associated Protein Kinase Family
por: Wang, Qingshui, et al.
Publicado: (2021)

Serum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity
por: Zhu, Huijuan, et al.
Publicado: (2018)

SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
por: Lourenco, Mychael V., et al.
Publicado: (2019)

FNDC5/Irisin – Their Role in the Nervous System and as a Mediator for Beneficial Effects of Exercise on the Brain
por: Wrann, Christiane D.
Publicado: (2015)

The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer
por: Wang, Qingshui, et al.
Publicado: (2021)

Can Resistance Exercise Alter Irisin Levels and Expression Profiles of FNDC5 and UCP1 in Rats?
por: Reisi, Jalil, et al.
Publicado: (2016)

Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity
por: Zhou, Xin, et al.
Publicado: (2019)

Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-Small Cell Lung Cancer
por: Nowinska, Katarzyna, et al.
Publicado: (2019)

Iditarod, a Drosophila homolog of the Irisin precursor FNDC5, is critical for exercise performance and cardiac autophagy
por: Cobb, Tyler, et al.
Publicado: (2023)

FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle
por: Varela-Rodríguez, B. M., et al.
Publicado: (2016)

FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020)

Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice
por: Jiang, Songling, et al.
Publicado: (2021)

Exercise-induced FNDC5/irisin protects nucleus pulposus cells against senescence and apoptosis by activating autophagy
por: Zhou, Wenxian, et al.
Publicado: (2022)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
por: Li, Hong, et al.
Publicado: (2019)

NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin
por: Li, Dong-Jie, et al.
Publicado: (2021)

FNDC5/Irisin Inhibits the Inflammatory Response and Mediates the Aerobic Exercise-Induced Improvement of Liver Injury after Myocardial Infarction
por: Wang, Tao, et al.
Publicado: (2023)

Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway
por: He, Wuyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72vuloju0i375rso2qgve5ppk8